Form 4 for RXST RxSight, Inc.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-03 · accession 0000950170-24-053667 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2024-05-06 | 2024-05-03 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $60.15 | -40.0K | 764.6K | -5% | -$2.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | S | D | 40,000 | $60.15 | 764,610 | I See footnote | — | — | (F2) Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $60.00 to $60.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse. |